Aldeyra Therapeutics Inc. (ALDX)
NASDAQ: ALDX
· Real-Time Price · USD
5.66
0.32 (5.99%)
At close: Oct 15, 2025, 3:59 PM
5.60
-1.06%
After-hours: Oct 15, 2025, 06:43 PM EDT
Aldeyra Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
Revenue | n/a | n/a | n/a | n/a |
Cost of Revenue | 249.62K | 262.78K | 258.71K | 264.18K |
Gross Profit | -249.62K | -262.78K | -258.71K | -264.18K |
Operating Income | -60.12M | -42.79M | -62.68M | -56.22M |
Interest Income | 6.19M | 7.32M | 2.35M | 185.36K |
Pretax Income | -55.85M | -37.54M | -62.02M | -57.78M |
Net Income | -55.85M | -37.54M | -62.02M | -57.78M |
Selling & General & Admin | 11.89M | 13.34M | 15.37M | 11.28M |
Research & Development | 48.23M | 29.46M | 47.31M | 44.94M |
Other Expenses | n/a | n/a | n/a | n/a |
Operating Expenses | 60.12M | 42.79M | 62.68M | 56.22M |
Interest Expense | 1.93M | 2.07M | 1.69M | 1.74M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a |
Cost & Expenses | 60.12M | 42.79M | 62.68M | 56.22M |
Income Tax Expense | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 59.48M | 58.94M | 58.41M | 54.04M |
Shares Outstanding (Diluted) | 59.48M | 58.94M | 58.41M | 54.04M |
EPS (Basic) | -0.94 | -0.64 | -1.06 | -1.07 |
EPS (Diluted) | -0.94 | -0.64 | -1.06 | -1.07 |
EBITDA | -53.68M | -35.21M | -60.07M | -55.77M |
EBIT | -53.93M | -35.47M | -60.33M | -56.03M |
Depreciation & Amortization | 249.62K | 262.78K | 258.71K | 264.18K |
Source: Financial Modeling Prep. Financial Sources.